Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Revenue

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹3,454 Cr₹3,252 Cr₹3,278 Cr₹2,926 Cr₹3,224 Cr

What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Revenue ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹3,454 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹3,454 Cr
Mar2024₹3,252 Cr
Mar2023₹3,278 Cr
Mar2022₹2,926 Cr
Mar2021₹3,224 Cr

How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹3,454 Cr
6.21
Mar2024 ₹3,252 Cr
-0.80
Mar2023 ₹3,278 Cr
12.05
Mar2022 ₹2,926 Cr
-9.27
Mar2021 ₹3,224 Cr -

Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹54,924.6 Cr -1.2% -2.3% 27.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹181,397.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.2%

-2.3%

27.2%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses